﻿<?xml version="1.0" encoding="utf-8"?><!--RSS Genrated: Mon, 20 Apr 2026 08:23:57 GMT--><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:ev="http://purl.org/rss/1.0/modules/event/"><channel><title>American Pharmacists Association</title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/March-2023/rss/1364</link><atom:link href="http://www.pharmacist.com/Publications/Pharmacy-Today/March-2023/rss/1364" rel="self" type="application/rss+xml" /><description>RSS document</description><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[New therapeutic agents marketed in 2022: Part 1]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/new-therapeutic-agents-marketed-in-2022-part-1</link><description><![CDATA[ CPE Assessment 

 This assessment must be taken online; please see “CPE information” in the sidebar on the previous page for further instructions. The online system will present these questions in ...]]></description><pubDate>Tue, 07 Mar 2023 18:13:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/new-therapeutic-agents-marketed-in-2022-part-1</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-1337]]></dc:identifier></item></channel></rss>